General Information of Drug Off-Target (DOT) (ID: OTUDD0QT)

DOT Name Actin-like protein 8 (ACTL8)
Synonyms Cancer/testis antigen 57; CT57
Gene Name ACTL8
Related Disease
Colorectal carcinoma ( )
Glioblastoma multiforme ( )
Adult glioblastoma ( )
Breast cancer ( )
Breast carcinoma ( )
Head-neck squamous cell carcinoma ( )
Testicular cancer ( )
Advanced cancer ( )
UniProt ID
ACTL8_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00022
Sequence
MAARTVIIDHGSGFLKAGTAGWNEPQMVFPNIVNYLPCKENPGPSYARRRVSLGIDICHP
DTFSYPIERGRILNWEGVQYLWSFVLENHRREQEVPPVIITETPLREPADRKKMLEILFE
LLHVPSVLLADQLQMSLYASGLLTGVVVDSGYGLTRVQPFHQGRPLPASGKTLEFAGQDL
SAYLLKSLFKEDCDRRCLFQLETVAVTQMNKCYVPQNLGEALDFRERQQSALDESNTYQL
PDGSRVELTPMQRVAPEMFFSPQVFEQPGPSIPRAIVESVESCEISLRPLLVSHVMACGG
NTLYPGFTKRLFRELMGDHVSSTKATVWEGSNRNFSVWLGASVVAHLSTYQSEWMSREEY
GEHMRM
Tissue Specificity Strongly expressed in testis and pancreas. Weak expression in placenta.

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [1]
Glioblastoma multiforme DISK8246 Strong Biomarker [2]
Adult glioblastoma DISVP4LU moderate Biomarker [2]
Breast cancer DIS7DPX1 moderate Biomarker [2]
Breast carcinoma DIS2UE88 moderate Biomarker [2]
Head-neck squamous cell carcinoma DISF7P24 moderate Altered Expression [2]
Testicular cancer DIS6HNYO moderate Biomarker [2]
Advanced cancer DISAT1Z9 Limited Biomarker [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Actin-like protein 8 (ACTL8). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Actin-like protein 8 (ACTL8). [8]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Actin-like protein 8 (ACTL8). [4]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Actin-like protein 8 (ACTL8). [5]
Triclosan DMZUR4N Approved Triclosan increases the expression of Actin-like protein 8 (ACTL8). [6]
Niclosamide DMJAGXQ Approved Niclosamide decreases the expression of Actin-like protein 8 (ACTL8). [7]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Actin-like protein 8 (ACTL8). [9]
------------------------------------------------------------------------------------

References

1 Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer.Onco Targets Ther. 2019 Mar 1;12:1749-1763. doi: 10.2147/OTT.S185858. eCollection 2019.
2 High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.Mol Med Rep. 2019 Feb;19(2):877-884. doi: 10.3892/mmr.2018.9716. Epub 2018 Dec 3.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
5 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
6 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
7 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.